Carlsmed

Contributing Author

Recent Articles by Carlsmed

Feb-11	Carlsmed Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026 CARL -5.15% GlobeNewswire
Feb-10	Carlsmed Announces First aprevo Bi-lateral Posterior Lumbar Interbody Fusion Procedure CARL GlobeNewswire
Jan-12	Carlsmed Announces Preliminary Revenue for the Fourth Quarter and Full Year 2025 CARL +13.79% GlobeNewswire
Jan-06	Carlsmed aprevo Lumbar 2-year Data Published in Global Spine Journal CARL GlobeNewswire
Dec-16	Carlsmed, Inc. To Participate in the J.P. Morgan 2026 Healthcare Conference CARL GlobeNewswire
Dec-03	Carlsmed Announces U.S. Launch of its aprevo Technology Platform for Cervical Fusion Surgeries at the Cervical Spine Research Society (CSRS) 53rd Annual Meeting CARL +12.44% GlobeNewswire
Nov-19	Carlsmed, Inc. To Participate in the Piper Sandler 37th Annual Healthcare Conference CARL GlobeNewswire
Nov-06	Carlsmed Reports Third Quarter 2025 Financial Results and Raises Full-Year Guidance CARL +14.89% CARL GlobeNewswire
Oct-23	Carlsmed Inc. to Report Third Quarter 2025 Financial Results on November 6, 2025 CARL -6.34% GlobeNewswire
Sep-29	Carlsmed, Inc. Appoints Jennifer Kamocsay as Chief Legal Officer and Secretary CARL GlobeNewswire
Sep-22	Carlsmed, Inc. Selected for Inclusion in Russell 2000 Index CARL GlobeNewswire
Aug-28	UPDATE - Carlsmed Reports Second Quarter 2025 Financial Results CARL GlobeNewswire
Aug-28	Carlsmed Reports Second Quarter 2025 Financial Results CARL GlobeNewswire
Aug-14	Carlsmed Inc. to Report Second Quarter 2025 Financial Results on August 28, 2025 CARL GlobeNewswire
Aug-01	Carlsmed's aprevo Personalized Interbody Implants Receive CMS New Technology Add-On Payment (NTAP) for Cervical Fusion Procedures CARL GlobeNewswire
Jul-28	Carlsmed's aprevo Powers First Personalized Cervical Spine Surgery CARL GlobeNewswire

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved.